文献速递颈动脉与弓上血管

头颈部放疗对颈动脉血运重建术后长期结局的影响

Impact of head and neck radiation on long-term outcomes after carotid revascularization.
PubMed 文献 · J Vasc Surg · 2024-04-01

本研究基于SVS VQI与VISION-Medicare关联数据库,纳入65岁及以上接受颈动脉血运重建(CEA、TCAR、CAS)的患者,比较放疗史与无放疗史者的长期结局。倾向性匹配后,放疗史显著增加CEA和CAS的死亡风险及CEA的3年卒中风险,而TCAR的长期结局未受显著影响。

要点

  • 放疗史显著增加CEA术后死亡风险(HR 1.77)和3年卒中风险(HR 1.47)。
  • 放疗史显著增加CAS术后死亡风险(HR 1.56)。
  • TCAR术后死亡和卒中风险未受放疗史显著影响。

核心结论

  • 既往头颈部放疗显著增加CEA术后的死亡和卒中风险,以及CAS术后的死亡风险。
  • TCAR的长期结局未受既往放疗显著影响。
  • 作者认为TCAR可能是放射性颈动脉狭窄患者的首选治疗方式。

研究设计与样本

  • 多中心注册数据库研究,使用SVS VQI注册中接受颈动脉干预(CEA、经股动脉CAS、TCAR)且年龄65岁及以上的患者。
  • 通过VQI VISION-Medicare关联数据库获取长期结局,共纳入56,472例患者(CEA n=48,307;TCAR n=4,593;CAS n=3,572),其中有放疗史1,244例,无放疗史54,925例。
  • 对放疗组与无放疗组进行倾向性匹配,匹配后共1,223例(CEA n=655;TCAR n=292;CAS n=287)。
  • 主要终点为3年死亡、卒中和再干预,采用Kaplan-Meier分析和多因素logistic回归模型分析。

主要发现

  • 放疗组男性比例更高(71.9% vs 60.3%;P < .01),接受支架比例更高(47.5% vs 13.5%;P < .01),P2Y12抑制剂使用比例更高(55.2% vs 38.3%;P < .01)。
  • 三种术式30天死亡、卒中或主要不良心血管事件均无显著差异。
  • CEA术后放疗组颅神经损伤率更高(3.7% vs 1.8%;P = .04),90天再入院率更高(23.5% vs 18.3%;P = .01)。
  • 放疗显著增加CEA死亡风险(HR 1.77;95%CI 1.38-2.27)和CAS死亡风险(HR 1.56;95%CI 1.02-2.36),并显著增加CEA的3年卒中风险(HR 1.47;95%CI 1.03-2.09)。
  • 放疗未显著影响TCAR的死亡和卒中风险,也未影响CEA、CAS或TCAR的短期和长期再干预率。

临床怎么用

  • 作者认为TCAR可能是放射性颈动脉狭窄患者的首选治疗方式。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Radiation-induced carotid artery stenosis (RICS) is a well-described phenomenon seen after head and neck cancer radiation. Previously published literature suggests that, compared with atherosclerotic disease, RICS may result in worse long-term outcomes and early restenosis. This study aims to evaluate the effect of radiation on long-term outcomes after various carotid revascularization techniques using a multi-center registry database. METHODS: Patients in the Society for Vascular Surgery (SVS) Vascular Quality Initiative (VQI) registry for carotid artery intervention (carotid endarterectomy [CEA]; transfemoral carotid artery stenting [CAS]; transcarotid artery revascularization [TCAR]), who are 65 years or older were included in the study. VQI Vascular Implant Surveillance and Interventional Outcomes Network (VISION) Medicare-linked database was used to obtain long-term procedure-specific outcomes. Primary endpoints were 3-year death, stroke, and reintervention. We performed propensity matching between patients with prior radiation and those without. Kaplan-Meier analysis and a multivariate logistic regression model were used to analyze the outcome variables. RESULTS: A total of 56,472 patients had undergone carotid revascularization (CEA, n = 48,307; TCAR, n = 4593; CAS, n = 3572), 1244 patients with prior radiation and 54,925 patients without prior radiation. The prior radiation group was more likely to be male (71.9% vs 60.3%; P < .01), to receive a stent (47.5% vs 13.5%; P < .01), and to be on P2Y12 inhibitor (55.2% vs 38.3%; P < .01). Propensity matching was performed on 1223 patients (CEA, n = 655; TCAR, n = 292; CAS, n = 287). There were no significant differences in 30-day outcomes for death, stroke, or major adverse cardiovascular events for all three procedures. The prior radiation group had higher rates of cranial nerve injury (3.7% vs 1.8%; P = .04) and 90-day readmission (23.5% vs 18.3%; P = .01) after CEA. For long-term outcomes, prior radiation significantly increased mortality risk for CEA and CAS (hazard ratio [HR], 1.77; 95% confidence interval [CI], 1.38-2.27 and HR, 1.56; 95% CI, 1.02-2.36, respectively). The 3-year risk of stroke for CEA in radiated patients was also significantly higher (HR, 1.47; 95% CI, 1.03-2.09) compared with non-radiated patients. Prior radiation did not significantly affect death and stroke in patients undergoing TCAR. Prior radiation also did not impact the rates of short and long-term reintervention after CEA, CAS, or TCAR. CONCLUSIONS: Prior head and neck radiation significantly increases the risk for mortality and stroke for CEA and the risk for mortality after CAS. Long-term outcomes for TCAR are not significantly affected by prior radiation. TCAR may be the preferred treatment modality for patients with radiation-induced carotid stenosis.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Lee KB, Tanenbaum MT, Wang A, et al. Impact of head and neck radiation on long-term outcomes after carotid revascularization. J Vasc Surg. 2024. PMID: 38570175. doi:10.1016/j.jvs.2024.03.441

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。